ZIVO BIOSCIENCE, INC. (ZIVO)

Every figure this model derived for ZIVO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-09-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2013-12-31
cash 57,222 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2025-09-30
current assets 281,399 AssetsCurrent 2025-09-30
current liabilities 3,614,268 LiabilitiesCurrent 2025-09-30
equity -3,286,603 StockholdersEquity 2025-09-30
interest expense 11,837 InterestPaidNet 2025-09-30
ocf -3,078,926 NetCashProvidedByUsedInOperatingActivities 2025-09-30
revenue 209,025 Revenues 2025-09-30
sbc 1,511,086 ShareBasedCompensation 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up ZIVO on one particular measure came for.

RatioValue
current ratio0.08
current ratio reported0.08
deferred revenue growth-100.0
dilution pct87.16
fcf margin-1472.99
interest cover-714.41
revenue growth164.52
revenue growth per share41.33
rule of 40-3881.13
sbc pct revenue722.92

What to be careful about

What this model itself distrusts about ZIVO's figures. Written by the derivation as it ran, not added afterwards.